Ted Karkus - Feb 1, 2023 Form 4 Insider Report for ProPhase Labs, Inc. (PRPH)

Role
CEO & CHAIRMAN, Director, 10%+ Owner
Signature
/s/ Ted Karkus
Stock symbol
PRPH
Transactions as of
Feb 1, 2023
Transactions value $
-$1,894,997
Form type
4
Date filed
2/2/2023, 03:33 PM
Previous filing
Jan 17, 2023
Next filing
Apr 4, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PRPH Common Stock, par value $0.005 Options Exercise $300K +500K +14.92% $0.60* 3.85M Feb 1, 2023 Direct F1
transaction PRPH Common Stock, par value $0.005 Tax liability -$2.19M -268K -6.97% $8.18 3.58M Feb 1, 2023 Direct F1
holding PRPH Common Stock, par value $0.005 100K Feb 1, 2023 By Son

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRPH Option (right to buy) Options Exercise $0 -500K -100% $0.00* 0 Feb 1, 2023 Common Stock 500K $0.60 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On February 1, 2023, the Reporting Person acquired net 231,663 shares of common stock upon the exercise of stock options to purchase 500,000 shares of common stock, less 268,337 shares of common stock withheld to cover the exercise price and applicable taxes.
F2 The option vested in 35 equal monthly installments of 63,888 shares on the 1st day of each month beginning on March 1, 2018 (the "Initial Vesting Date"), and one monthly installment of 63,920 shares on the 1st day of the 36th month following the Initial Vesting Date, as described in a stock option award agreement by and between the Issuer and the Reporting Person, dated as of February 19, 2018.